Lamothe Jeffrey G. 4
4 · Aptevo Therapeutics Inc. · Filed Aug 9, 2024
Insider Transaction Report
Form 4
Lamothe Jeffrey G.
EVP, COO
Transactions
- Exercise/Conversion
Common Stock
2024-08-08+42→ 894 total - Exercise/Conversion
Common Stock
2024-08-08+272→ 1,166 total - Exercise/Conversion
Restricted Stock Unit
2024-08-08−272→ 0 total→ Common Stock (272 underlying) - Exercise/Conversion
Restricted Stock Unit
2024-08-08−42→ 41 total→ Common Stock (42 underlying)
Footnotes (3)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]On August 9, 2022, the reporting person was granted 5,500 (125 post-split) RSUs, vesting in three approximately equal annual installments beginning on August 8, 2023.
- [F3]On August 9, 2022, the reporting person was granted 23,958 (544 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023.